Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)

B. Keam; R. J. Kreitman; Z. A. Wainberg; M. E. Cabanillas; D. C. Cho; A. Italiano; A. Stein; J. Y. Cho; J. H.M. Schellens; P. Y. Wen; C. C. Zielinski; A. D. Boran; B. Mookerjee; P. Burgess; F. Rangwala; V. Subbiah

doi:10.1093/annonc/mdy302.002

Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)

B. Keam, R. J. Kreitman, Z. A. Wainberg, M. E. Cabanillas, D. C. Cho, A. Italiano, A. Stein, J. Y. Cho, J. H.M. Schellens, P. Y. Wen, C. C. Zielinski, A. D. Boran, B. Mookerjee, P. Burgess, F. Rangwala, V. Subbiah

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	viii645-viii646
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy302.002
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy302.002

Cite this

Keam, B., Kreitman, R. J., Wainberg, Z. A., Cabanillas, M. E., Cho, D. C., Italiano, A., Stein, A., Cho, J. Y., Schellens, J. H. M., Wen, P. Y., Zielinski, C. C., Boran, A. D., Mookerjee, B., Burgess, P., Rangwala, F., & Subbiah, V. (2018). Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii645-viii646. https://doi.org/10.1093/annonc/mdy302.002

Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC). / Keam, B.; Kreitman, R. J.; Wainberg, Z. A. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii645-viii646.

Research output: Contribution to journal › Article › peer-review

Keam, B, Kreitman, RJ, Wainberg, ZA, Cabanillas, ME, Cho, DC, Italiano, A, Stein, A, Cho, JY, Schellens, JHM, Wen, PY, Zielinski, CC, Boran, AD, Mookerjee, B, Burgess, P, Rangwala, F & Subbiah, V 2018, 'Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii645-viii646. https://doi.org/10.1093/annonc/mdy302.002

@article{7c4aea1c2fa64bbc92d2e615bc0774c1,

title = "Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)",

author = "B. Keam and Kreitman, {R. J.} and Wainberg, {Z. A.} and Cabanillas, {M. E.} and Cho, {D. C.} and A. Italiano and A. Stein and Cho, {J. Y.} and Schellens, {J. H.M.} and Wen, {P. Y.} and Zielinski, {C. C.} and Boran, {A. D.} and B. Mookerjee and P. Burgess and F. Rangwala and V. Subbiah",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy302.002",

language = "English (US)",

volume = "29",

pages = "viii645--viii646",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)

AU - Keam, B.

AU - Kreitman, R. J.

AU - Wainberg, Z. A.

AU - Cabanillas, M. E.

AU - Cho, D. C.

AU - Italiano, A.

AU - Stein, A.

AU - Cho, J. Y.

AU - Schellens, J. H.M.

AU - Wen, P. Y.

AU - Zielinski, C. C.

AU - Boran, A. D.

AU - Mookerjee, B.

AU - Burgess, P.

AU - Rangwala, F.

AU - Subbiah, V.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85074002344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074002344&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy302.002

DO - 10.1093/annonc/mdy302.002

M3 - Article

C2 - 32137753

SN - 0923-7534

VL - 29

SP - viii645-viii646

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this